Adiuvo Diagnostics

Nellore, India Founded: 2015 • Age: 11 yrs Minicorn
Provider of digital products to detect skin diseases and infections

About Adiuvo Diagnostics

Adiuvo Diagnostics is a Healthcare company based in Nellore (India) founded in 2015 by Geethanjali Radhakrishnan. Adiuvo Diagnostics has raised $2 million across 6 funding rounds from investors including Anthem Biosciences, IQVIA and Villgro. The company has 26 employees. Adiuvo Diagnostics was last valued at $1.96 million in February 2020. Its chief executive, as recorded, is Geethanjali Radhakrishnan. Its Indian entity Adiuvo Diagnostics Private Limited reported revenue of β‚Ή7.17 Cr. Adiuvo Diagnostics offers products and services including Illuminate and Illuminate Dashboard. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.

Company details

Provider of digital products to detect skin diseases and infections. The companys flagship product is Illuminate is a wound infection screening device which uses artificial intelligence that provides a label free, non contact gram type bacterial recognition.

Key Metrics
  • Annual Revenue
    ₹7.17 Cr

    FY 2024 · +381% YoY

  • Net Profit
    ₹2.74 Cr

    FY 2024 · 38% margin

  • EBITDA
    ₹2.86 Cr

    FY 2024 · 40% margin

  • Total Equity Funding
    $2M (USD)

    in 6 rounds

  • Investors
  • Employee Count
    26

Products & Services of Adiuvo Diagnostics

Adiuvo Diagnostics offers a comprehensive portfolio of products and services, including Illuminate and Illuminate Dashboard.

Illuminate
Imaging Device

Captures multispectral images for quick disease diagnostics in low-resource settings.

Illuminate Dashboard
Software Platform

Manages diagnostic data using machine learning algorithms for healthcare applications.

Funding Insights of Adiuvo Diagnostics

Adiuvo Diagnostics has successfully raised a total of $2M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2M
  • Total Rounds 6
  • First Round $96,605

    (Feb 2017)

  • Investors Count 6

All 6 funding rounds of Adiuvo Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023Grant––
Dec 2020$4,056Grant––
Feb 2020$769,621Seed$1.96MMenterra Venture Advisors, Artha Impact
–
Feb 2019$182,423Seed$1.19MMenterra Venture Advisors
–
Dec 2018$949,472Seed$β€’β€’β€’β€’β€’Menterra Venture Advisors
Feb 2017$96,605Seed–Villgro
–
Valuation history
DateValuationStage
Feb 2020$1.96Mβ€’β€’β€’β€’β€’β€’β€’β€’
Feb 2019$1.19Mβ€’β€’β€’β€’β€’β€’β€’β€’
Dec 2018$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Adiuvo Diagnostics

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $1.96M (Feb 2020). 6 investors in total: 6 institutional.

Investors in Adiuvo Diagnostics

Adiuvo Diagnostics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Anthem Biosciences, IQVIA and Villgro.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Business incubation services are provided across multiple sectors.
birac.nic.inDelhi, India
Investments in social impact sectors such as agriculture, healthcare, and education in India.
2015menterra.comBengaluru, India
Impact investing services are provided in agriculture, healthcare, and livelihoods through platforms and networks.
arthaimpact.com
Incubation of social enterprises in climate-smart agriculture, healthcare, and climate action sectors.
2001villgro.orgChennai, India
Developer of integrated contract research development and manufacturing services
2007anthembio.comBengaluru, India
Clinical research and commercialization solutions are provided for healthcare.
1982iqvia.comDurham, United States
Premium access

Investor details for Adiuvo Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Adiuvo Diagnostics Private Limited (Adiuvo Diagnostics)

Adiuvo Diagnostics Private Limited is the primary company behind Adiuvo Diagnostics. The board of Adiuvo Diagnostics Private Limited currently have 3 directors; the longest-serving is Radhakrishnan Geethanjali, appointed in 2015. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Radhakrishnan Geethanjali
DIN 07297797
Managing Director29 Dec 201510 yrs 10 moAdiuvo Diagnostics Private Limited
George Thomas
DIN 00068470
Nominee Director30 Jan 20206 yrs 9 moAdiuvo Diagnostics Private Limited
Balasubrahmanyam Pesala
DIN 09004227
Director29 Nov 20241 yr 11 moAdiuvo Diagnostics Private Limited

People of Adiuvo Diagnostics

1 people are tracked at Adiuvo Diagnostics (1 in leadership); the tracked headcount is 26.

NameRoleGroup
Founder & CEOLeadership
Premium access

Complete people profiles for Adiuvo Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Adiuvo Diagnostics

Figures of Adiuvo Diagnostics Private Limited, the primary company behind Adiuvo Diagnostics, for FY 2024. Revenue was ₹7.17 Cr (+381% year on year). Net profit was ₹2.74 Cr (38% margin). EBITDA was ₹2.86 Cr (40% margin). Revenue has grown at a compounded annual rate of +144% over three years and +130% over five years.

  • ₹7.17 CrRevenue · FY 2024 · +381% YoY
  • ₹2.74 CrNet profit · 38% margin
  • ₹2.86 CrEBITDA · 40% margin
  • ₹2.2 LakhPaid-up capital
  • 26Employees (provident fund records)
  • +144%Revenue CAGR, 3 years
  • +130%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Adiuvo Diagnostics Private Limited are on its company page.

Premium access

Detailed financial statements for Adiuvo Diagnostics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Adiuvo Diagnostics

4 dated milestones of Adiuvo Diagnostics across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Adiuvo Diagnostics is founded.
  2. Funding First funding round of $97K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Grant,.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Adiuvo Diagnostics

Adiuvo Diagnostics was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Adiuvo Diagnostics is headquartered in Nellore, India. It is registered at Nellore, Andhra Pradesh, India.

Geethanjali Radhakrishnan is the CEO of Adiuvo Diagnostics, as recorded in our data. They have also founded this company.

Adiuvo Diagnostics is a funded company, having raised a total of $2M across 6 funding rounds to date. The company's 1st funding round was a Seed of $96.61K, raised on Feb 2017.

Adiuvo Diagnostics has 26 employees.

The primary company behind Adiuvo Diagnostics, Adiuvo Diagnostics Private Limited, reported revenue of β‚Ή7.17 Cr for FY 2024, up 381% year on year.

Provider of digital products to detect skin diseases and infections. The companys flagship product is Illuminate is a wound infection screening device which uses artificial intelligence that provides a label free, non contact gram type bacterial recognition.

Adiuvo Diagnostics offers Illuminate and Illuminate Dashboard.

Adiuvo Diagnostics has 6 investors. Key investors include Anthem Biosciences, IQVIA, Villgro, Menterra Venture Advisors, and BIRAC.

The valuation of Adiuvo Diagnostics is $1.96M as of Feb 2020.

Adiuvo Diagnostics operates through Adiuvo Diagnostics Private Limited.

The legal entities of Adiuvo Diagnostics currently have 4 directors, including Radhakrishnan Geethanjali, George Thomas, Balasubrahmanyam Pesala and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available